Form 4: Indaptus Therapeutics COO Cancels Stock Options, Receives $500 Consideration

Sentiment:

SEC Form 4 Filing


Walt Addison Linscott, Chief Operating Officer of Indaptus Therapeutics, Inc., canceled several stock option grants by mutual agreement, receiving $500 in consideration.

Summary

  • Walt Addison Linscott, the Chief Operating Officer of Indaptus Therapeutics, Inc. (INDP), filed a Form 4 on April 11, 2025, reporting changes in beneficial ownership.
  • The report indicates that Linscott canceled multiple stock option grants by mutual agreement with the company on April 10, 2025.
  • As consideration for the cancellation, Linscott received a total of $500.
  • The canceled options had various grant dates and exercise prices, but all were canceled on the same day.
  • Following the cancellation, Linscott no longer holds any of the derivative securities (stock options) previously reported.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The cancellation of options and receipt of $500 is a relatively small transaction and doesn't inherently indicate positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock option management, common in publicly traded companies. It doesn't necessarily indicate a broader trend within the biotechnology industry but reflects internal decisions at Indaptus Therapeutics.

Key Dates

DateDescription
12/11/2017Original grant date of one of the canceled stock option grants.
01/22/2019Original grant date of one of the canceled stock option grants.
02/17/2020Original grant date of one of the canceled stock option grants.
09/13/2019Original grant date of one of the canceled stock option grants.
09/16/2020Original grant date of one of the canceled stock option grants.
04/10/2025Date of stock option cancellation.
04/11/2025Date of Form 4 filing.

Keywords

Form 4, Indaptus Therapeutics, Stock Options, Beneficial Ownership, Walt Addison Linscott, INDP, COO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.